The present disclosure relates to Birt-Hogg-Dube syndrome, nucleic acids
encoding the BHD gene, and methods of using the nucleic acids and
proteins encoded thereby. In particular, the present disclosure relates
to methods of diagnosing BHD disease and related conditions, such as
spontaneous pneumothorax and kidney cancer, and methods of treating BHD
skin lesions.